Tobramycin and vestibulotoxicity: retrospective analysis of four cases

Over a course of 7 months, four patients developed vestibulotoxicity after treatment with intravenous tobramycin. Authors advise that symptoms of dizziness and balance disorders should be recognised by patients and carers at an early stage to prevent further deterioration.

Source:

European Journal of Hospital Pharmacy